$HSTM
HEALTHSTREAM INC Stock $hstm

$hstm Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922010086 Filed on April 28, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$65.37M	$63.47M
YoY Change	2.99%	3.08%
Cost Of Revenue	$22.00M	$21.24M
YoY Change	3.57%	4.32%
Gross Profit	$43.37M	$42.23M
YoY Change	2.7%	2.48%
Gross Profit Margin	66.35%	66.54%
Selling, General & Admin	$19.60M	$20.42M
YoY Change	-4.02%	7.19%
% of Gross Profit	45.19%	48.35%
Research & Development	$10.41M	$9.525M
YoY Change	9.31%	27.54%
% of Gross Profit	24.01%	22.56%
Depreciation & Amortization	$9.322M	$9.153M
YoY Change	1.85%	22.88%
% of Gross Profit	21.49%	21.67%
Operating Expenses	$10.41M	$9.525M
YoY Change	9.31%	27.54%
Operating Profit	$4.035M	$3.300M
YoY Change	22.27%	-54.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$276.0K	-$87.00K
YoY Change	217.24%	-105.09%
Pretax Income	$3.759M	$3.213M
YoY Change	16.99%	-64.1%
Income Tax	$900.0K	$922.0K
% Of Pretax Income	23.94%	28.7%
Net Earnings	$2.893M	$2.291M
YoY Change	26.28%	-67.7%
Net Earnings / Revenue	4.43%	3.61%
Basic Earnings Per Share	$0.09	$0.07
Diluted Earnings Per Share	$0.09	$0.07
COMMON SHARES
Basic Shares Outstanding	30.96M	31.50M
Diluted Shares Outstanding	30.98M	31.53M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.38M	$55.97M
YoY Change	-18.92%	-60.58%
Cash & Equivalents	$43.37M	$45.35M
Short-Term Investments	$2.008M	$10.62M
Other Short-Term Assets	$9.872M	$21.80M
YoY Change	-54.72%	-8.79%
Inventory
Prepaid Expenses
Receivables	$35.74M	$37.20M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$107.2M	$115.0M
YoY Change	-6.76%	-42.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.07M	$47.90M
YoY Change	-64.36%	-10.63%
Goodwill	$182.8M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.767M	$7.800M
YoY Change	-13.24%	81.4%
Other Assets	$938.0K	$24.30M
YoY Change	-96.14%	34.25%
Total Long-Term Assets	$376.7M	$386.7M
YoY Change	-2.58%	37.7%
TOTAL ASSETS
Total Short-Term Assets	$107.2M	$115.0M
Total Long-Term Assets	$376.7M	$386.7M
Total Assets	$483.9M	$501.7M
YoY Change	-3.54%	4.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.77M	$20.00M
YoY Change	-11.15%	21.95%
Accrued Expenses	$6.914M	$8.500M
YoY Change	-18.66%	-37.96%
Deferred Revenue	$89.88M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$114.6M	$116.9M
YoY Change	-2.0%	14.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.465M	$31.40M
YoY Change	-95.33%	8695.52%
Total Long-Term Liabilities	$1.465M	$31.40M
YoY Change	-95.33%	8695.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$114.6M	$116.9M
Total Long-Term Liabilities	$1.465M	$31.40M
Total Liabilities	$116.0M	$164.9M
YoY Change	-29.64%	12.87%
SHAREHOLDERS EQUITY
Retained Earnings	$71.02M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$322.6M	$336.8M
YoY Change
Total Liabilities & Shareholders Equity	$483.9M	$501.7M
YoY Change	-3.54%	4.19%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$2.893M	$2.291M
YoY Change	26.28%	-67.7%
Depreciation, Depletion And Amortization	$9.322M	$9.153M
YoY Change	1.85%	22.88%
Cash From Operating Activities	$20.66M	$19.10M
YoY Change	8.12%	212.36%
INVESTING ACTIVITIES
Capital Expenditures	$636.0K	$1.898M
YoY Change	-66.49%	87.92%
Acquisitions	$22.00K	$731.0K
YoY Change	-96.99%	-96.59%
Other Investing Activities	$2.979M	-$2.440M
YoY Change	-222.09%	-83.55%
Cash From Investing Activities	-$3.962M	-$9.660M
YoY Change	-58.99%	-51.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$19.73M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$20.22M	-$411.0K
YoY Change	4820.44%	-96.0%
NET CHANGE
Cash From Operating Activities	$20.66M	$19.10M
Cash From Investing Activities	-$3.962M	-$9.660M
Cash From Financing Activities	-$20.22M	-$411.0K
Net Change In Cash	-$3.535M	$8.782M
YoY Change	-140.25%	-136.42%
FREE CASH FLOW
Cash From Operating Activities	$20.66M	$19.10M
Capital Expenditures	$636.0K	$1.898M
Free Cash Flow	$20.02M	$17.21M
YoY Change	16.35%	236.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30391600
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	541000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	853000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19270000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17999000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	90537000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	86097000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30518
CY2022Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	30518
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31327
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	31327
CY2022Q1	hstm	Sales Commissions Amortization Term SalesCommissionsAmortizationTerm	P3Y
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30308000	USD
CY2022Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43370000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46905000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2008000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	5041000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35739000	USD
CY2022Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5049000	USD
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	4612000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	32412000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	68122000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	378000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	106000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24589000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	322572000	USD
CY2022Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	11188000	USD
CY2021Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	9155000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	9872000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10824000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	107226000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	106845000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17070000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17950000	USD
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	34131000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25168000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	182785000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	182501000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	601000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	601000	USD
CY2022Q1	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	24142000	USD
CY2021Q4	hstm	Contract With Customer Asset Sales Commission Noncurrent ContractWithCustomerAssetSalesCommissionNoncurrent	24012000	USD
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	6767000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	7043000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	938000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1016000	USD
CY2022Q1	us-gaap	Assets Assets	483926000	USD
CY2021Q4	us-gaap	Assets Assets	486753000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17770000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	21497000	USD
CY2022Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6914000	USD
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5037000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	89878000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	73816000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	114562000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	100350000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18841000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18146000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	990000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1583000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25496000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26178000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1465000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1477000	USD
CY2022Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	251179000	USD
CY2021Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	270791000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	71015000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	339019000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	483926000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	486753000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65367000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63468000	USD
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	21998000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10412000	USD
CY2021Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	22748000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	278000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	230000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	272000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	234000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3165000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9322000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9153000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9525000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10417000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9019000	USD
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9183000	USD
CY2021Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9723000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9322000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9153000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	61332000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	60168000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4035000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3300000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-276000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3759000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3213000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	866000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	922000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2291000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30955000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31504000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30976000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31526000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2291000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2525000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	339019000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	272000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	774000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-498000	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	19888000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	322572000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	334062000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2291000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	234000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	616000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-399000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	336805000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2291000	USD
CY2022Q1	hstm	Gain Loss On Non Marketable Equity Investments GainLossOnNonMarketableEquityInvestments	-276000	USD
CY2021Q1	hstm	Gain Loss On Non Marketable Equity Investments GainLossOnNonMarketableEquityInvestments	-54000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3962000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	616000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	774000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9660000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	497000	USD
CY2022Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2484000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2133000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	399000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	142000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	684000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	486000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19726000	USD
CY2021Q1	hstm	Non Cash Paid Time Off Expense NonCashPaidTimeOffExpense	-1011000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-26000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-15000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	636000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1898000	USD
CY2022Q1	hstm	Non Cash Paid Time Off Expense NonCashPaidTimeOffExpense	0	USD
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5874000	USD
CY2021Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-7379000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	2033000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	2215000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-952000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2521000	USD
CY2022Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	2614000	USD
CY2021Q1	hstm	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	3602000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-79000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	76000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3653000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5339000	USD
CY2022Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	1877000	USD
CY2021Q1	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-305000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15456000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6862000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20655000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19104000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	22000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	731000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5025000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4500000	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2024000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5205000	USD
CY2022Q1	hstm	Payments To Acquire Non Marketable Equity Investments PaymentsToAcquireNonMarketableEquityInvestments	-0	USD
CY2021Q1	hstm	Payments To Acquire Non Marketable Equity Investments PaymentsToAcquireNonMarketableEquityInvestments	1000000	USD
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	6305000	USD
CY2021Q1	us-gaap	Payments For Software PaymentsForSoftware	5326000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-0	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	12000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20223000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-411000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-251000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3535000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8782000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46905000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36566000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43370000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45348000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	33600000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	444000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.44	pure
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q1	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	100000	USD
CY2022Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2500000	USD
CY2021Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2100000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65367000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63468000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	34600000	USD
CY2021Q1	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	100000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23	pure
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.29	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	616000	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	218000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	148000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2893000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	2291000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30955000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31504000
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21000
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	22000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30976000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31526000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2016000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2008000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5043000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5041000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65367000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63468000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4035000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3300000	USD
CY2022Q1	us-gaap	Assets Assets	483926000	USD
CY2021Q4	us-gaap	Assets Assets	486753000	USD

Files In Submission

Name	View Source	Status
0001437749-22-010086-index-headers.html	Edgar Link	pending
0001437749-22-010086-index.html	Edgar Link	pending
0001437749-22-010086.txt	Edgar Link	pending
0001437749-22-010086-xbrl.zip	Edgar Link	pending
ex_343176.htm	Edgar Link	pending
ex_343177.htm	Edgar Link	pending
ex_343178.htm	Edgar Link	pending
ex_343179.htm	Edgar Link	pending
ex_358139.htm	Edgar Link	pending
ex_365233.htm	Edgar Link	pending
ex_365234.htm	Edgar Link	pending
ex_365235.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hstm-20220331.xsd	Edgar Link	pending
hstm-20220331_cal.xml	Edgar Link	unprocessable
hstm-20220331_def.xml	Edgar Link	unprocessable
hstm-20220331_lab.xml	Edgar Link	unprocessable
hstm-20220331_pre.xml	Edgar Link	unprocessable
hstm20220331_10q.htm	Edgar Link	pending
hstm20220331_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HSTM
HEALTHSTREAM INC Stock $hstm

2022 Q1 Form 10-Q Financial Statement

#000143774922010086 Filed on April 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM HEALTHSTREAM INC Stock $hstm

2022 Q1 Form 10-Q Financial Statement

#000143774922010086 Filed on April 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTM
HEALTHSTREAM INC Stock $hstm